Erythropoietin Drugs Market worth US$ 25.9 Billion 2030 with a CAGR of 8.9 %



The report "Global Erythropoietin Drugs Market, by Drug Class (Biologics and Biosimilar), by Product (Epoetin-Alfa, Epoetin-Beta, Darbepoetin-Alfa, and Others (Pegylated Erythropoietin and Carbamylated Erythropoietin)), by Application (Cancer, Hematology, Renal diseases, and Neurology), and Region - Global Forecast to 2029" 

Erythropoietin Drugs Market accounted for US$ 11 billion in 2020 and is estimated to be US$ 25.9 billion by 2030 and is anticipated to register a CAGR of 8.9%. This is attributed to increasing prevalence of anemia, caner, chronic kidney disease, bone marrow dysfunction, and HIV, coupled with rising incidences of deficiency of iron, vitamin B12, and folic acid due to desk-bound lifestyle.

Key Highlights:

  • On May 2018, Pfizer Inc. announced that United States Food and Drug Administration (USFDA) approved “RETACRIT” (epoetin alfa-epbx)  a biosimilar to Epogen and Procrit (epoetin alfa).
  • In December 2018, Celltrion, Inc and Teva Pharmaceutical Industries Ltd announced that U.S.FDA had approved of HERZUMA (trastuzumab-pkrb). It is a biosimilar to herceptin for the treatment of her2-overexpressing breast cancer for certain indications.

Key Market Insights from the report:          

The Global Erythropoietin Drugs Market accounted for US$ 11 billion in 2020 and is estimated to be US$ 25.9 billion by 2030 and is anticipated to register a CAGR of 8.9%.The market report has been segmented on the basis of drug class, product, application, and region.

  • By drug class, the global erythropoietin drugs market is segmented into biologics and biosimilar.
  • By product, the global erythropoietin drugs market is bifurcated into epoetin-alfa, epoetin-beta, darbepoetin-alfa, and others. Others product sub-segment is classified into pegylated erythropoietin and carbamylated erythropoietin.
  • By application, the global erythropoietin drugs market is segmented into cancer, hematology, renal diseases, and neurology.
  • By region, North America erythropoietin drugs market is accounted for major revenue share of the global erythropoietin drugs market and is further anticipated to maintain its dominance over the forecast period, owing to patent expiration of biologics and various players have entered the market in countries of the region. Europe erythropoietin drugs market is accounted for significant market share in the global erythropoietin drugs market in 2019.

Before purchasing this report, request a sample or make an inquiry by clicking the following link:

https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/2230

The prominent player operating in the global erythropoietin drugs market includes Johnson & Johnson, Celltrion, Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Amgen, Inc, F. Hoffmann-La Roche Ltd., LG Life Sciences Ltd., Biocon Limited, Intas Pharmaceuticals Ltd, Sun Pharmaceutical Industries Ltd, and Dr. Reddy’s Laboratories Ltd.

About Prophecy Market Insights

Prophecy Market Insights is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business.

Contact Us:

Sales

Prophecy Market Insights

Email- sales@prophecymarketinsights.com

Comments

Post a Comment

Popular posts from this blog

Antibody Drug Conjugate Market is estimated to be US$ 27.0 billion by 2030 with a CAGR of 23.5% during the forecast period

Image
  Antibody drug conjugate market accounted for US$ 3.3 billion in 2020 and is estimated to be US$ 27.0 billion by 2030 and is anticipated to register a CAGR of 23.5% . Antibody-drug conjugates or ADCs are biopharmaceutical drugs designed for targeted therapy for treating various type of cancer. ADCs are expose to target and kill tumor cells while sparing healthy cells. As of now 59npharmaceutical companies developed ADCs. These are complex molecules composed of antibody and have capability to target cancer cells by discriminating healthy tissues and diseased tissues. The report "   Global Antibody Drug Conjugate Market, By Technology (Cleavable Linker and Non-Cleavable Linker), By Application (Blood Cancer, Ovarian Cancer, Lung Cancer and Brain Tumor), By Distribution Channel (Hospital Pharmacies, Online Pharmacies and Others) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030”...
Read more

Inulin Market is estimated to be US$ 2.29 billion by 2030 with a CAGR of 5.5% during the forecast period

Image
  The report "Global Inulin Market , By Application (Food and Beverage, Dietary Supplements, and Pharmaceutical) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030”. Increasing awareness about prebiotic ingredients and their extensive utilization in food and beverages industry is the major factor driving the growth of the global inulin market globally. Inulin has various applications in dairy product formation such as cheese, yogurts, and ice-cream. Hence, the growth in dairy industries is projected to boost additional growth in inulin market over the forecast period. Also, high growth in the pharmaceuticals industry worldwide is propelling the growth of the target market. Furthermore, the fast-growing significance of nutraceuticals due to increasing health awareness is expected to increase demand for inulin as a functional ingredient. Key Highlights: In June 2018, Cosucra’s inulin-type fru...
Read more

Intraocular Lens Market is estimated to be US$ 7.9 billion by 2032 with a CAGR of 7.2% over the forecast period (2022-2032)

Image
  The Intraocular Lenses implant is routinely utilized during cataract surgery. Intraocular Lenses work as natural lenses. Lens implant has various focusing powers like prescription contact lenses or eyeglasses. There are different types of Intraocular Lenses like – Monofocal IOLs, which has one focal point & can be set to focus on close, medium, and distance vision which is based on preference. Distance vision is the most common selection. Trifocal IOLs, help to see better in distance, computer distance, and reading distance. Trifocal IOLs help in allowing to see both the distance and near while looking in any kind of direction. Toric IOLs is used if one has significant eye astigmatism. Astigmatism result when cornea flatter in one direction like a football. Toric Intraocular Lenses are designed for correcting astigmatism and allows to have great vision without glasses. Phakic lenses are commonly used for correcting moderate to severe nearsightedness. Phakic lenses are surgic...
Read more